Who
Michael T. Sember
Director
Company insider
Files Form 4 as: Director, Quoin Pharmaceuticals; Director, Iomed; Chief Executive Officer, Soligenix.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 7 Dec 2004
- Last trade
- 4 Feb 2026
- Last filed
- 6 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Feb 2026filed 6 Feb 2026 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,141 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,141 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,760 at $0.00 | filing |
| 9 Dec 2024filed 10 Dec 2024 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,714 at $0.00 | filing |
| 26 Oct 2023filed 30 Oct 2023 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,652 at $0.00 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $26K15,000 at $1.72 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $38K15,000 at $2.55 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $36K15,000 at $2.43 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $33K15,000 at $2.20 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $18K15,000 at $1.17 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $28K15,000 at $1.89 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $98K15,000 at $6.50 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $39K10,000 at $3.88 | filing |
| 9 Aug 2007filed 13 Aug 2007 | Iomedoption or derivative | SEC FORM 4 Code D | $23K10,000 at $2.25 | filing |
| 9 Nov 2006filed 13 Nov 2006 | Iomedoption or derivative | SEC FORM 4 Code A | $26K15,000 at $1.72 | filing |
| 10 Apr 2006filed 10 Apr 2006 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,440 at $0.00 | filing |
| 10 Apr 2006filed 10 Apr 2006 | SNGX SoligenixBiotechnology | SEC FORM 4 Code A | $81K180,440 at $0.45 | filing |
| 10 Apr 2006filed 10 Apr 2006 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,440 at $0.00 | filing |
| 10 Apr 2006filed 10 Apr 2006 | SNGX SoligenixBiotechnology | SEC FORM 4 Code A | $51K180,440 at $0.28 | filing |
| 7 Dec 2004filed 10 Apr 2006 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.